Authors' Reply to Liedgens and Henske: "Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective"

Applied health economics and health policy

PubMedID: 23907656

Wielage RC, Bansal M, Andrews JS, Klein RW, Happich M. Authors' Reply to Liedgens and Henske: "Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective". Appl Health Econ Health Policy. 2013;.
An abstract is not available. Please access the article through the links below.